金达莱拟以2.8亿元增资济慈医疗

Core Viewpoint - Jindalai (688057) plans to invest 280 million yuan in Yunnan Jici Medical Technology Co., Ltd., acquiring a 34% stake to enhance its business and competitiveness [1] Group 1: Investment Details - The investment amount is 280 million yuan [1] - After the investment, Jindalai will hold a 34% equity stake in Jici Medical [1] Group 2: Business Focus - Jici Medical and its subsidiaries focus on the research and application of autologous cell technology [1] - The company has developed autologous rFib injection solutions that have undergone safety and efficacy validation for over 30 clinical indications [1] Group 3: Strategic Objectives - The purpose of the investment is to expand Jindalai's business and enhance its profitability [1] - The investment aims to improve the company's overall competitiveness and influence [1] - It is intended to promote the sustainable development of the company [1]